Coronavirus: Vaccination

(asked on 13th April 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using a different covid-19 vaccine to Oxford-AstraZeneca for under 30 year olds who have already had their first dose of that vaccine.


Answered by
Nadhim Zahawi Portrait
Nadhim Zahawi
This question was answered on 21st April 2021

There is currently no trial data available on the immune responses to mixed COVID-19 vaccine schedules. Such data are being developed by the National Immunisation Schedule Evaluation Consortium and will be considered by the Joint Committee on Vaccination and Immunisation (JCVI) when available. The JCVI advises that all those who have received a first dose of the Oxford/AstraZeneca COVID-19 vaccine should continue to be offered a second dose of that vaccine, irrespective of age. The second dose will be important for longer lasting protection against COVID-19. The JCVI’s statement on the use of the Oxford/AstraZeneca vaccine is available at the following link:

https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement/jcvi-statement-on-use-of-the-astrazeneca-covid-19-vaccine-7-april-2021

Reticulating Splines